Gordon Loewen
Impact in
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Pain Management and Opioid Use 5
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Roger K. VerbeeckJ.L. BlackburnJ A TrugliaJames R. RigasMark G. KrisFrancesca BenedettiGeorge M. GillE H Ulm
- Journals
- Journal of Clinical Oncology (3 papers)Neurology (2 papers)Pain Medicine (2 papers)Alzheimer s & Dementia (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Gordon Loewen
36 papers receiving 820 citations
Peers
Comparison fields: 5 of 87
- Biochemistry 94
- Dermatology 92
- Pharmacology 83
- Pharmacology 159
- Anesthesiology and Pain Medicine 52
Countries citing papers authored by Gordon Loewen
This map shows the geographic impact of Gordon Loewen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Loewen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Loewen more than expected).
Fields of papers citing papers by Gordon Loewen
This network shows the impact of papers produced by Gordon Loewen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Loewen. The network helps show where Gordon Loewen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gordon Loewen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 1 | |
| 3 | Pharmacokinetics of Opicapone and Effect on Comt and Levodopa Pharmacokinetics in Patients with Parkinson's Disease | 2019 | 2 |
| 4 | 2018 | 1 | |
| 5 | 2016 | 52 | |
| 6 | 2012 | 34 | |
| 7 | 2007 | 7 | |
| 8 | 2005 | 5 | |
| 9 | 2002 | 12 | |
| 10 | 2002 | 13 | |
| 11 | 2002 | 44 | |
| 12 | 2001 | 3 | |
| 13 | 2000 | 46 | |
| 14 | 2000 | 12 | |
| 15 | 2000 | 1 | |
| 16 | Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group. | 1999 | 5 |
| 17 | 1998 | 6 | |
| 18 | 1997 | 158 | |
| 19 | 1995 | 1 | |
| 20 | 1989 | 22 |
About Gordon Loewen
Gordon Loewen is a scholar working on Anesthesiology and Pain Medicine, Pharmacology, Pharmacology, Biochemistry and Dermatology, having authored 38 papers that have together received 861 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (10 papers), Estrogen and related hormone effects (6 papers), Pain Management and Opioid Use (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Biochemistry (94 citations), Dermatology (92 citations), Pharmacology (83 citations), Pharmacology (159 citations) and Anesthesiology and Pain Medicine (52 citations). Gordon Loewen has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Roger K. Verbeeck, J.L. Blackburn, J A Truglia, James R. Rigas, Mark G. Kris, Francesca Benedetti, George M. Gill, E H Ulm, Daniel A. Straus and R P Warrell. Their work appears in journals such as Journal of Clinical Oncology, Neurology, Pain Medicine, Alzheimer s & Dementia and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.